MIR2355

Across TCGA pan-cancer cohorts, MIR2355 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated MIR2355 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher MIR2355 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR2355 expression acts as an unfavorable survival marker, although some lineages such as UCS and PAAD show a favorable association.

UCS, LIHC, and CESC are the cancer types where MIR2355 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	III,IV	0.806	0.199	.011	108	view →
LIHC	OS	Tertile	II,III,IV	0.153	0.782	<.001	75	view →
CESC	DFS	Tertile	III,IV	0.259	0.671	.005	54	view →
THYM	OS	Tertile	All	0.689	0.977	.002	36	view →
ACC	DFS	Tertile	IV	0.012	0.310	.002	36	view →
THCA	OS	Tertile	III,IV	0.840	0.986	.003	33	view →
UCEC	DFS	Tertile	All	0.766	0.904	<.001	30	view →
KIRP	OS	Tertile	III,IV	0.201	0.716	<.001	27	view →
COAD	DFS	Tertile	II,III,IV	0.588	0.763	.008	18	view →
LUSC	OS	Tertile	III,IV	0.182	0.794	.002	18	view →
PAAD	OS	Quartile	II,III,IV	0.802	0.543	.011	14	view →
UVM	DFS	Tertile	III,IV	0.189	0.685	.037	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

MIR2355–UCS (DFS)

Open the UCS breakdown →